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Usual walking performance following rehab 1 
 2 
Circuit-based rehabilitation improves gait endurance but not usual walking 3 
activity in chronic stroke: a randomised clinical trial. 4 
5 
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Abstract 6 
 7 
Objective: To determine if circuit-based rehabilitation would increase the 8 
amount and rate of walking that an individual with stroke carries out in their 9 
usual environment. 10 
Design: Single blind randomised controlled trial 11 
Setting: Rehabilitation clinic 12 
Participants: Sixty participants with a residual gait deficit at least six months 13 
following stroke originally enrolled in the study. Two withdrew in the initial phase 14 
leaving 58 participants (median age 71.5 years (range 39.0-89.0)) who were 15 
randomised to the two intervention groups. 16 
Interventions: The exercise group had 12 sessions of clinic-based 17 
rehabilitation delivered in a circuit class designed to improve walking. The 18 
control group received a comparable duration of group social and educational 19 
classes.  20 
Main Outcome Measures: Usual walking performance was assessed using the 21 
StepWatch Activity Monitor. Clinical tests were gait speed (timed 10 metre walk) 22 
and endurance (Six minute walk test), confidence (Activities-Based Confidence 23 
Scale), self reported mobility (Rivermead Mobility Index) and self-reported 24 
physical activity (Physical Activity and Disability Scale). 25 
Results: Intention-to-treat analysis revealed that the exercise group showed a 26 
significantly greater distance for the 6MWT compared to the control group 27 
immediately following the intervention (p=0.030) but that this effect was not 28 
retained three months later.  There were no changes in the StepWatch 29 
measures of usual walking performance for either group. The exercise and 30 
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control groups had significantly different gait speed (p=0.038) and scores on the 31 
RMI (p=0.025) at the three-month follow-up. These differences represented a 32 
greater decline in the control group compared to the exercise group for both 33 
outcome measures..  34 
Conclusions: Circuit-based rehabilitation leads to improvements in gait 35 
endurance but does not change the amount or rate of walking performance in 36 
usual environments. Clinical gains made by the exercise group were lost three 37 
months later. Future studies should consider whether rehabilitation needs to 38 
occur in usual environments in order to improve walking performance. 39 
 40 
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Introduction 43 
 44 
Persistent physical disability is reported by 50-65% of individuals with stroke 45 
making it the leading cause of long term disability in adults.1-3 Although most 46 
recovery occurs in the first six months following stroke,4 there is mounting 47 
evidence that rehabilitation beyond this time may result in further gains.5, 6 48 
 49 
Walking remains a major focus of physical therapy programmes,7 although the 50 
specific components of training that optimise walking recovery are less certain. 51 
Task oriented gait training, including walking in all directions, over different 52 
surfaces, obstacles, inclines and steps, consistently results in improved clinical 53 
measures of gait, particularly self selected gait speed and endurance.8-14  54 
 55 
Strength training has been included in some physical therapy programmes with 56 
more variable results.15 There is relatively consistent evidence for gains in 57 
strength when progressive resistance principles are applied.16-18 However, the 58 
translation of benefits from strength training to functional activities, such as 59 
walking, is less clear.18 The variable results seen in different studies may reflect 60 
differences in strength training protocols,19 as some studies do not demonstrate 61 
evidence of adequate overload of the muscle.20, 21  62 
 63 
Although rehabilitation leads to measurable gains in walking speed and 64 
endurance, and amelioration of impairments, it is not known whether these 65 
improvements translate into an improvement in function once an individual 66 
returns to their own environment.22 The aim of this study was to determine if 67 
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rehabilitation, delivered as a circuit exercise programme, would increase the 68 
amount and rate of walking that an individual with stroke carries out in their 69 
usual environment.  70 
 71 
Methods 72 
 73 
This is a prospective, randomised, single-blind, attention-controlled clinical trial 74 
of circuit-based rehabilitation in adults at least six months after stroke. 75 
Participants were a convenience sample recruited through the Stroke 76 
Foundation of New Zealand, stroke clubs and the local hospital stroke service. 77 
Information sheets about the study were provided to potential candidates who 78 
were invited to contact the principal investigator if they wished to participate. 79 
The study was approved by the Regional Ethics Committee and each 80 
participant provided informed consent. Procedures were conducted in 81 
accordance with the Declaration of Helsinki. 82 
 83 
Participants were eligible for inclusion if they had had one or more strokes more 84 
than six months earlier, had been discharged from rehabilitation and were able 85 
to walk independently (with an aid if necessary). Some residual gait difficulty 86 
was required, as defined by a score of less than 2 on at least one of the walking 87 
items of the physical functioning scale of the 36 Item Short Form Health 88 
Survey.23 Participants were excluded if they had progressive neurological 89 
disease, other significant health problems that adversely affected walking 90 
ability, more than two falls in the previous six months, unstable cardiac 91 
conditions, uncontrolled hypertension or congestive heart failure. A letter 92 
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detailing the proposed programme and inclusion and exclusion criteria was sent 93 
to each participant’s general practitioner for medical clearance prior to 94 
enrolment in the study.  95 
 96 
Participants were randomly assigned to the exercise or control group through 97 
the use of computer generated random numbers by an individual not associated 98 
with the study. Randomisation was revealed to each participant by the principal 99 
investigator following their second baseline assessment. 100 
 101 
Participants allocated to the exercise group participated in 12 group circuit 102 
exercise sessions three times a week for four weeks. The groups contained up 103 
to nine participants and were led by one of the investigators (SM) assisted by 104 
two physiotherapy students. There were 15 stations in the circuit, which were 105 
graded to each participant’s ability and progressed as tolerated. Each station 106 
contained either a task-oriented gait or standing balance activity or 107 
strengthening of a lower extremity muscle in a way designed to improve gait. 108 
Details of the content of each station and examples of progressions are 109 
provided in Appendix 1. The total exercise time was 30 minutes, although 110 
sessions lasted between 50-60 minutes, including stretching. Participants spent 111 
two minutes at each station of the circuit, with time between stations to allow 112 
movement between stations and receive instructions for the next station. Details 113 
about exercise intensity and/or repetitions performed at each station were 114 
recorded for each participant.  115 
 116 
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Participants in the control group attended eight 90 minute sessions over four 117 
weeks in groups of up to eight. The control group was run by an occupational 118 
therapist and consisted of four social and four educational sessions. The 119 
content of the sessions is outlined in Appendix 2. The duration of the control 120 
group sessions was designed to match the length of the time of the intervention 121 
sessions in order to control for possible effects of dosage. Matching for duration 122 
and not number of sessions was a pragmatic choice based on resources, 123 
allowing one intervention session per weekday to be scheduled over the four 124 
week intervention period. Both the control and exercise group sessions took 125 
place in a private rehabilitation clinic. 126 
 127 
Outcome Measures  128 
The mean number of steps per day as measured by the StepWatch Activity 129 
Monitora was used as the primary outcome measure. The monitor contains a 130 
custom sensor that uses a combination of acceleration, position and timing to 131 
determine the number and rate of steps taken. The output of the StepWatch is 132 
based on the number of steps taken on one leg, which is doubled to represent 133 
steps taken on both legs.24-27 The StepWatch has been shown to have criterion 134 
validity28, 29 and is reliable25, 30 for step counting in individuals with stroke. 135 
Sensitivity has been demonstrated during the subacute phase of stroke.24  136 
 137 
The monitor was initially calibrated and attached to the lateral side of the ankle 138 
of the non-paretic leg with a strap or cuff. The monitor has an infrared light that 139 
flashes with every step, which were matched to a manual count of steps during 140 
walking five metres at each of three walking speeds (fast, slow and self 141 
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selected). The sensitivity and cadence settings were adjusted, if necessary, 142 
until the flashes corresponded exactly with the manual count during the three 143 
walking speeds. Participants were then instructed to wear the monitor for three 144 
consecutive days, removing it for sleeping and showering. Data were exported 145 
to Excelb for initial analysis. On subsequent testing sessions, participants were 146 
instructed to wear the StepWatch for the same three days of the week as worn 147 
following the first testing session. The consecutive StepWatch data was 148 
averaged over the three days.   149 
 150 
The secondary outcome measures were walking speed and endurance, 151 
confidence during mobility tasks and self reported activity. Participants used 152 
their usual assistive device for these two tests, and they were tested at 153 
subsequent sessions with the same assistive device. Self selected gait speed 154 
was measured by a timed 10 metre walk test where a person walks at 155 
comfortable pace over 10 metres. Gait endurance was tested by the six minute 156 
walk test (6MWT),31 although it should be acknowledged that the 6MWT is also 157 
influenced by other stroke-related impairments like balance and strength.32 Both 158 
the timed 10 metre walk and 6MWT are used commonly 33 and have good 159 
psychometric properties.34 160 
 161 
The Activities-specific Balance and Confidence scale (ABC) was used to reflect 162 
confidence during 15 activities of daily living. In the stroke population, the ABC 163 
has been shown to have high test-retest reliability 35, 36 and high internal 164 
consistency.36 Moderate correlation has been shown with the Berg Balance 165 
Scale, supporting criterion-related validity.35 166 
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 167 
The Rivermead Mobility Index (RMI) was used to capture self reported mobility. 168 
The RMI is a self report of ability to perform up to 15 mobility items (six 169 
specifically related to walking), with answers given of either “yes” or “no”. The 170 
RMI reflects a breadth of walking conditions, such as walking over uneven 171 
surfaces and walking outside that are not evaluated by the commonly used 172 
timed walking tests.33 The highest score of 15 indicates an ability to climb up 173 
and down four steps with no rail and run 10 metres. 174 
 175 
The Physical Activity and Disability Scale (PADS) was used to determine the 176 
level of activity performed by an individual. The PADS is specifically designed to 177 
reflect activities potentially performed by individuals with disabilities.37 178 
Satisfactory reliability (ICC = 0.85) and validity are reported by the developers 179 
of the scale.38  180 
 181 
Following the post-intervention testing session, each participant was asked 182 
whether they thought there had been any change in their walking over the 183 
intervention period and/or while they were wearing the StepWatch, and, if so, 184 
whether they thought the change related to quality, speed or quantity of 185 
walking.  186 
 187 
Outcome assessment was performed by an independent physiotherapist 188 
blinded to treatment assignment. Participants were not blinded, as they were 189 
aware of their own group allocation, which was revealed after the second 190 
testing session. Participants were instructed not to discuss group allocation with 191 
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the assessor. The testing sessions were carried out in the same rehabilitation 192 
clinic as the intervention groups, but were scheduled at different times to 193 
maintain blinding of the assessor. 194 
 195 
Two baseline testing sessions 3 weeks apart were performed to ensure that 196 
participant measures were stable. The testing sessions were repeated 197 
immediately following the group sessions (post-intervention) and at three 198 
months (follow-up). All tests were performed once and all testing sessions were 199 
identical.  200 
 201 
Statistical Analysis 202 
Baseline Data: Tests for normality were done for all continuous variables. 203 
Simple descriptive statistics were used to summarise demographic and 204 
baseline sample characteristics. The two baseline measures were tested for 205 
stability by using a coefficient of variation (standard deviation expressed as a 206 
percentage of the mean) and then averaged to yield baseline outcome 207 
measures. Baseline population characteristics were compared between 208 
intervention groups using Chi-Square or Fisher’s Exact tests for categorical 209 
variables, and Wilcoxon-Mann-Whitney tests for continuous variables. Analysis 210 
of variance (ANOVA) for unbalanced designs was used to test for group 211 
differences in baseline measures.  212 
 213 
Post-intervention measures: Intention to treat analysis was used for all 214 
outcomes with a carry forward method used to account for missing data.39 For 215 
each parametric outcome at post-intervention and 3-months follow-up, analysis 216 
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of covariance (ANCOVA) was used to test for intervention group differences 217 
with the baseline measure as the covariate. Wilcoxon Signed Rank-Sum test 218 
was used to assess whether there were intervention group differences at post-219 
intervention and 3-months follow-up, for non-parametric outcomes.. 220 
Calculations were performed using SASc . 221 
 222 
The power calculation was based on data from Michael et al,26 who reported 223 
2837  1503 mean steps/day in 50 participants with stroke. A 40% increase in 224 
mean steps/day was chosen as the smallest relevant difference, as this level of 225 
change reflects the smallest amount not attributable to normal daily variation. 30 226 
A sample size of 25 participants would therefore have  greater than 90% power 227 
to detect a 40% within-group change in mean steps/day, assuming a correlation 228 
coefficient of at least r=0.4, and a significance level of 0.05.  A sample size of 229 
25 participants in each group has 80% power to detect a 42% between-group 230 
change in mean steps/day, with a significance level of 0.05 231 
 232 
Results 233 
 234 
Sixty participants (median 71.5 years old (range 39-89) and median 3.9 years 235 
following stroke (range 0.5-18.7 years) were enrolled in the study between June 236 
2007 and February 2008. However, two participants withdrew before 237 
randomisation leaving 58 individuals who are the subject of this study (Figure 238 
1).  Thirty-one participants were randomised to the exercise group and 27 to the 239 
control group. The median score on the physical functioning index of the 36 240 
Item Short Form Health Survey was 17 for the control group and 19 for the 241 
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exercise group (range 10-28). A maximum score of 30 on the physical 242 
functioning index indicates no limitations with all items, including walking more 243 
than a mile, climbing several flights of stairs and running, whereas a score of 10 244 
indicates significant limitations with all items. All participants walked 245 
independently and 26 (45%) used an assistive device. There was no significant 246 
difference between the baseline characteristics of the two groups (Table 1).  247 
 248 
Of the 55 participants who completed the interventions, adherence to both 249 
groups was high with participants attending an average of 11.1 ± 1.7 hours (7.4 250 
± 1.2 sessions) in the control group and 10.8 ± 1.6 hours in the exercise group, 251 
both out of a possible 12 hours. Unmasking of the independent assessor 252 
occurred in the case of three participants, who inadvertently stated or implied 253 
their group allocation. 254 
 255 
Baseline  256 
Coefficients of variation calculated from the two baseline measures ranged from 257 
5.14% for the RMI to 21.30% for the PADS in the control group and 3.49% for 258 
the RMI to 34.67% for the PADS in the exercise group (Table 2). With the 259 
exception of the PADS for each group, the coefficients of variation were all 260 
under 15% and were under 10% for the 6MWT and gait speed.  261 
 262 
There were differences between control and exercise group clinical tests at 263 
baseline. The exercise group had greater distance on the 6MWT (p=0.028), 264 
mean steps/day (p=0.021), peak activity index (p=0.008) and highest step rate 265 
in one minute (p=0.019) (Table 2). Imbalances seen were likely to be due to 266 
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chance as they were collected while randomisation was concealed from the 267 
assessor and the participant. These differences were used as covariates in 268 
subsequent analysis. 269 
 270 
Post-intervention  271 
Table 3 shows the observed outcome scores at baseline, post intervention and 272 
at three months follow-up and the adjusted means, with the baseline values as 273 
covariates, at post intervention and follow-up. Immediately following the 274 
intervention, the exercise group showed a significantly greater distance for the 275 
6MWT compared to the control group (p=0.030) (Table 3). However, this did not 276 
translate into increased activity in the participants’ usual environments with no 277 
changes in any of the StepWatch outcomes in the exercise group. Subjective 278 
improvements in walking were noted by a greater proportion of the exercise 279 
group than the control group at the post-intervention testing session(p=0.042) 280 
but no changes were found in the self-report measures, RMI and PADS. The 281 
gains seen in the exercise group immediately following the intervention were 282 
not maintained at three months with a drop off in the 6MWT towards baseline 283 
values.  284 
 285 
The exercise and control groups had significantly different gait speed (p=0.038) 286 
and scores on the RMI (p=0.025) at the three-month follow-up. These 287 
differences represented a greater decline in the control group compared to the 288 
exercise group for both outcome measures. 289 
 290 
Discussion 291 
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This study has found that exercise-based rehabilitation led to early 292 
improvements in gait endurance but did not change the amount or rate of usual 293 
walking performance, as measured by the StepWatch Activity Monitor. 294 
Furthermore, gains made after the intervention were not retained three months 295 
later. 296 
 297 
Previous trials of rehabilitation exercise programmes in stroke have largely 298 
demonstrated improvements in clinical measures of up to 33%,8-11 but have not 299 
looked at carry-over of these gains into an individual’s usual environment. This 300 
study is novel as we have recorded a measure of usual walking performance in 301 
addition to standard clinical walking outcomes. No change could be 302 
demonstrated in any of the StepWatch outputs in the participants’ usual 303 
environment despite clinical improvements. These findings mirror the results of 304 
a 2004 study of 18 subjects with chronic heart failure, in which improvements in 305 
clinical measures following an aerobic training programme were not 306 
accompanied by a change in physical activity in the participants’ usual 307 
environments.40  308 
 309 
The majority of the participants in our study reported their walking improved and 310 
that they enjoyed the circuit classes and would have liked the opportunity to 311 
continue beyond the completion of the trial. This interest in exercise is 312 
consistent with the findings of a recent survey of individuals with stroke.41 Sixty-313 
nine percent of respondents did not exercise as much as they would like and 314 
84% reported they would be interested in an exercise programme if one were 315 
available. However, despite the participants’ enthusiasm and belief that their 316 
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walking had improved, this study shows that there was no change in usual 317 
walking activity. 318 
 319 
Exercise training has been shown to consistently increase overall physical 320 
activity levels in previously sedentary but healthy young adults.42-44 Non-training 321 
activity (usual activity that occurs at any other time than during training) remains 322 
constant44 but the added training activity results in an increase in overall 323 
physical activity. Substantial gains in the physical activity index from a pre-324 
training level of 1.6 for both men and women to 1.9 for women and 2.4 for men 325 
have been shown, where 1.5 is defined as light, 1.8 as moderate and 2.1 as 326 
high levels of activity.43 In contrast, the overall physical activity levels of healthy 327 
elderly subjects do not change when they participate in an exercise training 328 
programme.45-47  Instead, non-training physical activity is reduced, fully 329 
compensating for the increased exercise-related activity. In the current study, 330 
the median age of participants was 71.5 years. Thus participants in the exercise 331 
group may have acted in a similar manner to healthy elderly subjects by 332 
decreasing their non-training activity for the duration of the exercise 333 
programme. Future studies could investigate the possible confounding effect of 334 
this change in behaviour by monitoring usual activity during and after the 335 
exercise programme. 336 
 337 
It is also feasible that participants in this trial were already performing near their 338 
functional reserve.48, 49 This suggestion is supported by the relatively high mean 339 
steps/day of the exercise group (6679 ± 3792), at baseline in relation to other 340 
studies in stroke (1389 ± 798 steps/day;27 2821 ± 1527 steps/day50). This 341 
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number of steps is within normal limits for healthy older adults (6565 ± 1530 342 
steps/day51). If participants were already near or at their peak walking activity in 343 
usual environments, then further increases of usual walking activity are less 344 
achievable. Future studies could use mean number of steps/day as an 345 
additional criterion for study inclusion or exclusion. 346 
 347 
The gains in the 6MWT made by the exercise group were not retained at the 348 
follow up. In addition, the control group showed a greater decline in gait speed 349 
and the RMI than the exercise group at follow-up. The finding of loss of function 350 
over time for individuals with chronic stroke is disappointing, but is consistent 351 
with previous studies which have shown that improvements in gait speed are 352 
not sustained in the longterm. 11, 52  Arguably, clinical gains that are not 353 
accompanied by a change in usual performance are not likely to be lasting. 354 
 355 
This study is limited by the relatively small subject numbers, although there was 356 
sufficient power to detect a relevant change in the StepWatch outputs. The 357 
characteristics of our participants may limit the findings to a wider generalisation 358 
to other people with stroke, as this sample appeared to be higher functioning in 359 
terms of gait speed and total steps per day than reported in previous studies.  360 
 361 
The results of this study raise a number of clinical questions about whether 362 
rehabilitation in a clinical setting is optimal for changing usual walking 363 
performance. Although the circuit stations included task-oriented balance and 364 
gait tasks and attempted to simulate environments encountered outside the 365 
clinic (e.g. obstacle course, fast walking), it was, nevertheless, a safe clinical 366 
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environment, which may not adequately represent the complexity of walking in 367 
community settings. 53, 54 Furthermore, practice to encourage carry over to other 368 
environments was not specifically included in the exercise classes. 369 
Rehabilitation might be more successfully delivered in usual environments, 370 
where practice of real world activities is more meaningful, thus enhancing carry-371 
over. Future studies should consider whether rehabilitation needs to occur in 372 
community environments in order to improve usual walking performance. In 373 
addition, a gait endurance component was not included in the exercise circuit, 374 
which, if included, may have promoted carry over to the number of steps taken 375 
per day.27 However, there are likely to be other influences, such as personal 376 
and environmental factors which may also impact the amount of usual 377 
walking.55, 56  378 
 379 
Conclusions 380 
Circuit-based rehabilitation leads to an early improvement in gait endurance but 381 
does not change the amount or rate of usual walking performance. Clinical 382 
gains made by the exercise group were lost three months later. It is likely that 383 
there are other factors, besides physical performance that may have an 384 
influence on physical activity levels in this population group.  385 
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Figure 1. Flow of participants through trial 566 
567 
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(health n=1, 
another stroke n=1) 
Withdrew (n=3) 
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n=1) 
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 569 
Table 1. Baseline Characteristics of Each Group 
Variable 
Control 
(n-27) 
Experimental 
(n=31) 
p-value 
Demographics    
Median Age (range) (years) 71.0 (44.0-86.0) 76.0 (39.0-89.0) 0.755 
a
 
Sex    
Male 13 (48%) 19 (61%) 0.315 
b
 
Female 14 (52%) 12 (39%)  
Race    
NZ/European 21 (78%) 26 (84%) 0.390 
c
 
Maori 1 (4%) 3 (10%)  
Pacific Islander 2 (7%) 0 (0%)  
Other 3 (11%) 2 (6%)  
Assistive Device    
Walker 5 (19%) 2 (6%) 0.229 
c
 
Crutch 1 (4%) 0 (0%)  
Quad cane 2 (7%) 2 (6%)  
Straight cane 8 (30%) 6 (19%)  
None 11 (41%) 21 (68%)  
Stroke Characteristics    
Median Onset (range) (years) 5.8 (0.5-18.7) 3.33 (0.6-13.3) 0.242 
a
 
Location    
Right hemisphere 14 (52%) 20 (65%) 0.425 
c
 
Left hemisphere 12 (44%) 11 (35%)  
Brain stem/other 1 (4%) 0 (0%)  
Physical Functioning Index of SF-36     
Median (range) 17.0 (10.0-28.0) 19.0 (12.0-26.0) 0.360 
a
 
a
 Wilcoxon-Mann-Whitney Test 
b
 Chi-Square Test 
c
 Fisher’s Exact Test 
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Table 2. Means, Standard Deviations and Coefficients of Variation for Baseline Measures by 
Intervention Group 
      
Baseline Measure Control Exercise p-value 
a
 
Control Exercise  
 (n=27) (n=31)   
     
 Mean ± SD  %CV 
Clinical outcome measures      
      
Gait speed (m/s) 0.62±0.27 0.76±0.30 0.069 7.93% 7.77% 
      
Gait endurance 
(6MWT) (m) 
201±99 263±110 0.028 
9.48% 7.91% 
      
RMI (median, range)  
13.5 (9.0-
15.0) 
14.0 (6.5-
15.0) 
  0.282 
b
 
5.14% 3.49% 
      
ABC 6.03±1.68 6.86±2.03 0.097 12.16% 8.11% 
      
PADS 63.6±77.0 75.2±57.5 0.516 21.30% 34.67% 
      
StepWatch output      
      
Mean steps/day (steps) 4616±2618 6679±3792 0.021 14.86% 11.60% 
      
Peak activity index 
(steps/min) 
52.0±15.9 66.6±23.3 0.008 
8.43% 6.57% 
      
Max 1 (steps/min) 76.6±19.1 89.6±21.8 0.019 6.52% 4.97% 
      
Percentage time 
inactive (%) 
84.1±7.0 81.6±8.3 0.235 
2.20% 2.45% 
      
a 
Analysis of Variance (ANOVA) for unbalanced designs, unless specified 
 
  
b 
Wilcoxon-Mann-Whitney Test 
 
%CV = coefficient of variation between the two baseline testing sessions 
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Table 3. Observed and Adjusted Means for Outcome Measures by Intervention Group 
Outcome 
Measure 
Group Baseline        Post –Intervention        3 Month Follow-up  
  Observed 
mean±sd 
Observed 
mean±sd 
Adjusted 
mean±SE 
Observed 
mean±sd 
Adjusted 
mean±SE 
Gait speed 
(m/s) 
Control (n=27) 0.62±0.27 0.63±0.25 0.69±0.02 0.63±0.25 0.66±0.02 
Exercise (n=31) 0.76±0.30 0.79±0.28 0.73±0.02 0.77±0.26 0.72±0.02 
ANCOVA
a
   p=0.090  p=0.038 
Gait 
endurance 
(6MWT) (m) 
Control (n=27) 201±99 200±99 233±6.5 195±104 229±8.1 
Exercise (n=31) 263±110 282±117 253±6.0 277±125 247±7.6 
ANCOVA   p=0.030  p=0.116 
RMI
b
 
 
Control (n=27) 13.5, 9.0-15.0 14.0, 10.0-15.0 0.0, -5.0-2.0 14.0, 7.0-15.0 0.0, -4.0-1.5 
Exercise (n=31) 14.0, 6.5-15.0 14.0, 9.0-15.0 0.0, -2.0-4.0 14.0, 5.0-15.0 0.0, -2.5-1.5 
Wilcoxon Signed 
Rank-Sum Test 
  p=0.121  p=0.025 
ABC 
 
Control (n=27) 6.03±1.7 6.42±1.7 6.78±0.20 6.62±1.7 6.99±0.22 
Exercise (n=31) 6.86±2.0 7.36±1.9 7.05±0.19 7.12±2.1 6.80±0.20 
ANCOVA   p=0.339  p=0.538 
PADS 
 
Control (n=27) 63.6±77.0 60.9±67.2 65.8±8.2 62.2±72.5 66.6±10.5 
Exercise (n=31) 75.2±57.5 77.8±55.7 74.2±7.6 82.1±72.8 78.2±9.8 
ANCOVA   p=0.413  p=0.427 
Mean 
steps/day 
(steps) 
 
Control (n=27) 4616±2618 4370±2994 5359±390.1 4403±2961 5360±292.9 
Exercise (n=31) 6679±3792 6666±3966 5804±362.8 6393±3429 5559±272.5 
ANCOVA   p=0.418  p=0.629 
Peak activity 
index 
(steps/min) 
 
Control (n=27) 52.0±15.9 49.0±17.5 55.5±2.3 51.5±20.5 58.2±2.4 
Exercise (n=31) 66.6±23.3 67.1±22.8 61.5±2.1 63.7±21.5 57.8±2.2 
ANCOVA   p=0.071  p=0.918 
Max 1 
(steps/min) 
 
Control (n=27) 76.5±19.1 75.2±20.5 81.7±1.9 75.6±22.2 82.0±2.2 
Exercise (n=31) 89.6±21.8 90.7±21.9 85.0±1.7 87.7±21.9 82.1±2.1 
ANCOVA   p=0.205  p=0.965 
Percentage 
of time 
inactive (%) 
 
Control (n=27) 84.1±7.0 84.4±8.2 83.1±0.8 84.7±7.3 83.6±0.5 
Exercise (n=31) 81.6±8.3 81.9±8.3 83.0±0.8 82.0±7.4 83.0±0.5 
ANCOVA   p=0.926  p=0.422 
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a Analysis of Covariance (ANCOVA) with baseline measure as covariate, 
unless specified 
b Observed means for RMI are displayed as median, range. Adjusted means 
for RMI are displayed as median change from baseline, range 
sd=standard deviation; SE=standard error 
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Appendix 1. Content and progressions of circuit exercise programme 
 
Allow 2 minutes at each station (excluding changeover time) 
 
Exercise Station Progressions 
1. sit to stand Increase speed until can complete 30, then 
decrease seat height. 
2. self sway  Start near wall for support, sway from ankles 
forwards and backwards, progress by increasing 
amplitude, then progress to standing away from wall. 
3. standing balance Stand in parallel bars with feet close together, try 
and balance as long as possible. Progress by 
adding crossed arms and turns of upper body. 
Progress further to standing on one leg. 
4. step ups Start with low step, progress by increasing height of 
step. 
5. balance beam Step over balance beam leading with alternate feet. 
Progress by increasing speed. Progress further to 
cross-overs. 
6. standing hamstring curl Progress weight and repetitions. 
7. tandem walk Walk with feet touching line on floor. Progress to 
heel-toe. Progress further by decreasing speed, 
looking forward, crossing arms.  
8. swiss ball squats Progress depth of squat until thighs parallel with 
ground; add hold which can be progressed by 
increasing time, progress further by adding weights 
to hands. 
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9. tandem stance Start with hands on wall for balance; progress base 
of support until heel-toe, progress to centre of room, 
progress to arms crossed. 
10. calf raise Start with double calf raise; progress speed, 
progress to single calf raise, progress to jumps. 
11. backwards walk Start near wall for balance, progress to centre of 
room, progress to shuttle runs 
12. lunges Start holding on for support, progress depth of 
lunge, progress number on each leg, progress to no 
support. 
13. side leg lifts Progress weight and repetitions. 
14. marching in place Progress to marching with a weight, marching with 
no hand support, marching on mini tramp. 
15. obstacle course progress by increasing speed, varying obstacles 
 
Finish with 5 minutes stretching of major leg muscle groups 
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Appendix 2. General objectives for social and educational programme 
sessions 
 
1. Introductory Session and Adaptive Equipment Display. 
 Introduce participants to the groups and provide information on the types of 
groups that we will be running over the next 4 weeks. 
 Provide participants with relevant and useful information for everyday functioning. 
 Give participants an opportunity to share ideas and methods of carrying out 
ADL’s and to learn from each other. 
 To have a relaxed and open atmosphere and one in which participants will enjoy 
themselves. 
 
2. Bowls Group 
 Continue to build a familiar relaxed and friendly social atmosphere. 
 Provide participants with an opportunity to raise concerns or to discuss the 
previous group, and offer each other support. 
 Play a game which may be familiar to some. 
 Provide a new experience for those who have not played bowls before. 
 
3. Quiz Group 
 Continue to build a familiar relaxed and friendly social atmosphere. 
 Provide participants with an opportunity to raise concerns or to discuss the 
previous group, and offer each other support. 
 Provide a session which involves some intellectual stimulation and enjoyment. 
 Everybody will be able to participate in the group and contribute to their teams. 
 
4. Falls Prevention and Energy Conservation Group 
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 Continue to build a familiar relaxed and friendly social atmosphere. 
 Provide participants with an opportunity to raise concerns or to discuss the 
previous group and offer each other support. 
 Provide education and information about fatigue management, energy 
conservation and falls prevention which will be useful and practical for 
participants to use in their everyday lives.  
 
5. Board games group 
 Continue to build a familiar relaxed and friendly social atmosphere. 
 Provide participants with an opportunity to raise concerns or to discuss the 
previous group, and offer each other support. 
 Offer participants a selection of board games to play, they may choose to play in 
small groups or pick a game to play all together. 
 Provide an opportunity for participants to contribute equally to the group. 
 
6. Bowls Group 
 Continue to build a familiar relaxed and friendly social atmosphere. 
 Provide participants with an opportunity to raise concerns or to discuss the 
previous group, and offer each other support. 
 Play a game which all are familiar with. 
 
7. Prevention of Secondary Stoke 
 Continue to build a familiar relaxed and friendly social atmosphere. 
 Provide participants with an opportunity to raise concerns or to discuss the 
previous group, and offer each other support. 
 Provide and opportunity to discuss stoke and lifestyle changes which may help in 
improving health and possibly prevent further strokes in the future. 
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8. Café Outing 
 Closure of the social group. 
 Provide and opportunity for participants to feedback and reflect on the group and 
how they have benefited or otherwise from the group. 
   
 
 
 
 
 
 
 
 
